Human milk oligosaccharide

2'-Fucosyllactose

Human Milk Oligosaccharides (HMOs) are a group of complex carbohydrates that are found in human breast milk. They are the third largest solid component in human milk after lactose and lipids, and they play a crucial role in the development of the infant's immune system and gut microbiota. HMOs are unique to human milk; while oligosaccharides are present in the milk of other mammals, the variety and complexity of HMOs are not found elsewhere.

Composition and Structure

HMOs consist of a lactose core with chains of different sugars, including glucose, galactose, N-acetylglucosamine, fucose, and sialic acid. The structure of HMOs is highly diverse, with over 200 different HMOs identified. This diversity is due to the variable length of their sugar chains and the different linkages between the sugar molecules. The most abundant HMOs in human milk are 2'-fucosyllactose (2'-FL), lacto-N-neotetraose (LNnT), and 3-fucosyllactose (3-FL).

Functions

HMOs serve multiple functions in infant health and development:

• Prebiotic Function: HMOs promote the growth of beneficial gut bacteria, such as Bifidobacterium species, which are important for a healthy gut microbiota. This prebiotic effect supports the infant's digestive health and immune function.

• Anti-Pathogenic Properties: HMOs can prevent the binding of pathogenic bacteria and viruses to the gut lining, acting as decoy targets. This protective mechanism reduces the risk of infection and illness in infants.

• Immune System Development: HMOs modulate the immune response, promoting the maturation of the immune system. They influence the development of immune cells and the production of antibodies, contributing to the infant's ability to fight infections.

• Brain Development: Emerging research suggests that HMOs may also play a role in the development of the nervous system and cognitive functions, although the mechanisms are not yet fully understood.

Biosynthesis and Genetics

The biosynthesis of HMOs in the mammary gland involves several enzymes that add sugars to the lactose core. The composition of HMOs in breast milk varies among women and is influenced by genetic factors, particularly the mother's Lewis blood group and Secretor status. These genetic factors determine the presence or absence of specific HMOs, such as 2'-FL, which is not produced by non-secretor mothers.

Clinical Applications and Research

Given their beneficial effects on infant health, there is growing interest in adding HMOs to infant formula. Some HMOs, like 2'-FL, have been synthesized and are now added to certain infant formulas to mimic the benefits of breast milk. Research into HMOs is also exploring their potential therapeutic applications beyond infancy, including their role in preventing and treating various diseases, such as inflammatory bowel disease (IBD) and allergies.

Conclusion

Human Milk Oligosaccharides are a key component of breast milk, contributing to the nutritional, immunological, and developmental needs of infants. Their complex structure and diverse functions underscore the uniqueness of human milk and highlight the importance of breastfeeding for infant health. Ongoing research into HMOs continues to reveal new insights into their roles and potential applications in nutrition and medicine.